RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure
Shohei Fujii, Shigeki Kobayashi, Yaowei Chang, Junya Nawata, Ryosuke Yoshitomi, Shinji Tanaka, Michiaki Kohno, Yoshihide Nakamura, Hironori Ishiguchi, Takeshi Suetomi, Hitoshi Uchinoumi, Tetsuro Oda, Shinichi Okuda, Takayuki Okamura, Takeshi Yamamoto, Masafumi Yano
Topics & Concepts
Ryanodine receptor 2Ryanodine receptorMedicineInternal medicineDantroleneCardiologyVentricular remodelingHeart failureMyocardial infarctionVentricular tachycardiaLigationEndocrinologyReceptorCalciumCardiac electrophysiology and arrhythmiasIon channel regulation and functionCardiac Ischemia and Reperfusion